Advice You - Internet and Businesses Online

With the burgeoning online transaction market across finance and retail sectors and based upon the premise that a competitor is just a mouse click away, the need to ensure a smooth and efficient buying experience is of paramount import

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

ance.

Many early adopters of the bleeding edge web technologies reaped the rewards of being first to market and sell their products and services in a secure online environment. However, the world as we all know, is not static and with

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

new web technologies appearing every twelve months, coupled with the inheritance of disparate technologies through merger and acquisition activities, has left many organisations with what I term a 'technology hangover' that saps both f

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

nancial and human resource allocation from the ever-decreasing annual budget.

What companies now face is a plethora of different company web sites, each requiring constant attention, maintenance and development.

With the gradual migr

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

tion of prospects to online transactions, the associated online customer experience becomes critical to the success of the business. Research shows us that people don't generally go online to purchase goods - at least not initially. Wh

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

t they seek in general terms is information. If you provide them with the appropriate level of information during that session there is a reasonable chance of presenting a corresponding value proposition that will entice the prospect t

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

commit and buy your offering on impulse. If however, they experience problems during the data entry process, there is an 84% chance the prospect will abandon the activity and look elsewhere for a competitive offering. Having provided

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

hem with all of the information you have effectively made it difficult for them to buy.

And how will your business be made aware of this?

The bottom line answer is that whilst your web analysis software will give you the raw statisti

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

s on conversion, it will not identify the problem that the user encountered.

As a former enterprise software salesman myself, I am acutely aware that if you make a mistake during the sales cycle, you learn from it and vow never to rep

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

at that mistake in future. Unfortunately software isn't that clever and as a result, the mistakes in web site logic that are causing potential consumers to abandon the process today, will invariably be alienating a whole new generation

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

of prospects twelve months from now.

Another problem with sitting in the ivory tower, casting admiring glances over the site visitor statistics is that whilst you may have several thousand visitors each and every day, can you be sure

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

hat they are genuinely interested parties? I recently came across an example where one client was shocked to discover that over 3,000 of its daily visitors turned out to be search engine bots. Moreover, the robot hits were actually pro

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

ibiting around 80 genuinely interested prospects from accessing the site every day. Even at their conservatively estimated conversion rates this would result in around ?500,000 per annum in missed revenues. The business itself has b

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

en operating for a number of years blissfully unaware of this and as a result they have now taken positive action to address this. And was this discovered after an elongated, expensive sales process and an equally arduous implementatio

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

and roll-out?

The answer, rather amazingly is that this was all discovered in a week-long proof of concept. Needless to say, the company quickly elected to purchase and adopt the technology as a core part of its strategic analysis.

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

any companies are evolving their web analytics by employing page-tagging, whereby each page has additional code inserted, allowing analytical software to report on it at appropriate times. The problem here is that web sites change and

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

row at an amazing rate and the initial wooden dollar cost of implementing this could be as high as ?150,000. This doesn't even factor in the ongoing maintenance and support costs, the margin for human coding error or the lack of depth

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

f the analysis.

My advice would be to avoid page-tagging projects and look for a robust solution that facilitates page analysis as an integral part of the product offering, obviating the need for additional coding.

There are solution

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

available today that will give you the ability to passively monitor your customer's online experience without impacting the performance of your site. Each session can be recorded and replayed by customer experience and helpdesk person

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

el without compromising user security. I have heard of examples where these processes have been used in dispute resolution cases and for customer support people to follow up on abandoned transactions, thereby protecting revenue streams

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.adviceyou.org.ua/article/86639/adviceyou-Transactional-Web-Site-Owners-May-be-Deluded.html">Transactional Web Site Owners May be Deluded</a>

BB link (for phorums):
[url=http://www.adviceyou.org.ua/article/86639/adviceyou-Transactional-Web-Site-Owners-May-be-Deluded.html]Transactional Web Site Owners May be Deluded[/url]

When the EEOC sued Ralph Loren because one of their photo shoots needed all blondes in it and denied a brunette an audition, one could conclude that political correctness and employment lawsuits hit an all time low. Swim suit models who were dark haired complained that they did not get the part? Die your hair for the week.

To navigate these fertile markets and increase your market share it is important that you understand brand dynamics. Sadly, many manufactures do not. They will plow these new waters with the same reckless brand management that has led them to believe that their domestic success is a result of something other than heavy advertising spending. Understanding how a brand’s permission sets the stage for future success in the market is essential, and the lessons are even more telling when you move the brand into a different culture.

Don't spend money to make money online. There are many programs out there that can provide you with a monthly income without spending a dime.

Tags

Links

Advice You - Transactional Web Site Owners May be Deluded

Related Articles: